Nikolaos Vassiliou, MD | |
80 Shunpike Rd, Suite 301, Cromwell, CT 06416-4401 | |
(860) 632-5570 | |
(860) 358-8650 |
Full Name | Nikolaos Vassiliou |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 16 Years |
Location | 80 Shunpike Rd, Cromwell, Connecticut |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1851554349 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 050996 (Connecticut) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Middlesex Hospital | Middletown, CT | Hospital |
Pilgrim Manor | Cromwell, CT | Nursing home |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mhs Primary Care, Inc | 4082507371 | 143 |
News Archive
In a letter addressed to Dr. Margaret Hamburg, the FDA commissioner, Ms. Norma Erickson, president of S.A.N.E. Vax, Inc. stated her research team has revealed the fact that in November 2001 the VRBPAC (Vaccines and Related Biological Products Advisory Committee) mistakenly allowed the vaccine manufacturer to use "CIN 2/3, AIS, or cervical cancer; i.e. CIN 2/3 or worse by histology- with virology to determine the associated HPV type- as the primary endpoint in the evaluation of a vaccine to prevent cervical cancer."
Resolving complex ethical, social and cultural issues in the early stage of a global health research project or clinical trial can improve the impact and quality of that research, a new report says.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
The Medical University of South Carolina (MUSC), one of the nation's top academic health science centers, and Alliance Oncology, a division of Alliance HealthCare Services, Inc., announce a newly formed affiliation designed to strengthen and expand MUSC's Hollings Cancer Center as the radiation therapy market leader in Charleston, South Carolina.
According to two studies by the Centers for Disease Control and Prevention (CDC), African Americans in the U.S. continue to be disproportionately affected by stroke.
› Verified 6 days ago
Entity Name | Mhs Primary Care, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740666312 PECOS PAC ID: 4082507371 Enrollment ID: O20040202000945 |
News Archive
In a letter addressed to Dr. Margaret Hamburg, the FDA commissioner, Ms. Norma Erickson, president of S.A.N.E. Vax, Inc. stated her research team has revealed the fact that in November 2001 the VRBPAC (Vaccines and Related Biological Products Advisory Committee) mistakenly allowed the vaccine manufacturer to use "CIN 2/3, AIS, or cervical cancer; i.e. CIN 2/3 or worse by histology- with virology to determine the associated HPV type- as the primary endpoint in the evaluation of a vaccine to prevent cervical cancer."
Resolving complex ethical, social and cultural issues in the early stage of a global health research project or clinical trial can improve the impact and quality of that research, a new report says.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
The Medical University of South Carolina (MUSC), one of the nation's top academic health science centers, and Alliance Oncology, a division of Alliance HealthCare Services, Inc., announce a newly formed affiliation designed to strengthen and expand MUSC's Hollings Cancer Center as the radiation therapy market leader in Charleston, South Carolina.
According to two studies by the Centers for Disease Control and Prevention (CDC), African Americans in the U.S. continue to be disproportionately affected by stroke.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Nikolaos Vassiliou, MD 28 Crescent St, Middletown, CT 06457-3654 Ph: (860) 358-4820 | Nikolaos Vassiliou, MD 80 Shunpike Rd, Suite 301, Cromwell, CT 06416-4401 Ph: (860) 632-5570 |
News Archive
In a letter addressed to Dr. Margaret Hamburg, the FDA commissioner, Ms. Norma Erickson, president of S.A.N.E. Vax, Inc. stated her research team has revealed the fact that in November 2001 the VRBPAC (Vaccines and Related Biological Products Advisory Committee) mistakenly allowed the vaccine manufacturer to use "CIN 2/3, AIS, or cervical cancer; i.e. CIN 2/3 or worse by histology- with virology to determine the associated HPV type- as the primary endpoint in the evaluation of a vaccine to prevent cervical cancer."
Resolving complex ethical, social and cultural issues in the early stage of a global health research project or clinical trial can improve the impact and quality of that research, a new report says.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
The Medical University of South Carolina (MUSC), one of the nation's top academic health science centers, and Alliance Oncology, a division of Alliance HealthCare Services, Inc., announce a newly formed affiliation designed to strengthen and expand MUSC's Hollings Cancer Center as the radiation therapy market leader in Charleston, South Carolina.
According to two studies by the Centers for Disease Control and Prevention (CDC), African Americans in the U.S. continue to be disproportionately affected by stroke.
› Verified 6 days ago
Sarah B Fortin, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Shunpike Rd Unit 301, Cromwell, CT 06416 Phone: 860-358-5280 Fax: 860-358-8650 | |
Kristen Donato, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Shunpike Rd, Cromwell, CT 06416 Phone: 860-632-5570 Fax: 860-358-8650 | |
Dr. Linda J Weiss, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Shunpike Rd, Suite 301, Cromwell, CT 06416 Phone: 860-632-5570 Fax: 860-358-8650 | |
Malisa Lynn Lahtinen, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Shunpike Rd, Suite 301, Cromwell, CT 06416 Phone: 860-632-5570 Fax: 860-358-8650 | |
Dr. Ryan J. Brenza, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Shunpike Rd Unit 301, Cromwell, CT 06416 Phone: 860-358-5280 Fax: 860-358-8650 | |
Stephen J Siegel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Shunpike Rd, Suite 301, Cromwell, CT 06416 Phone: 860-632-5570 Fax: 860-358-8650 | |
Marta J Kroo, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 136 Berlin Rd, Cromwell, CT 06416 Phone: 860-632-5570 Fax: 860-635-0097 |